Beijing-based Immunochina Pharmaceuticals has closed a RMB140 million ($20.5 million) Series C round with support from a group of investors including PayPal co-founder Peter Thiel.
SBI Crypto Investment, a unit of Japan’s SBI Holdings formed to back digital asset-focused start-ups, has invested $15 million in Tangem, a Switzerland-based producer of blockchain smart card wallets.
Warung Pintar, an Indonesia-based smart kiosk start-up, has raised IDR390 billion ($27.5 million) in Series B funding from a group of investors including East Ventures.
Ekuaibao, a Chinese corporate cost management software-as-a-service (SaaS) provider has raised $15 million in a Series B round of funding led by Mandra Capital, with participation from existing investors DCM Ventures and Future Capital.
Shandong province-based biologics and biopharmaceutical contract development and manufacturing organization (CDMO) MabPlex has raised RMB400 million ($59 million) in Series A funding led by SDIC Venture Capital and Shenzhen Capital Group.
Venture capital deals involving DCM, Sinovation Ventures, Langsheng Investment, United Capital, Shenzhen Capital, Capital Fortune Investment, Tiantu Capital, IDG Capital, Shunwei Capital, and Sky9 Capital
Aberdeen Standard Investments has committed $13 million to financial technology start-up Singapore Life, taking the company’s total capital raised to date to $97 million.
Belt Road Capital Management, a Cambodia-based private equity firm focused on Southeast Asia, has led a $7 million investment in Vietnamese e-commerce player LeFlair.
Ping An Insurance and CITIC Group have made a Series B investment of undisclosed size in Airdoc, a Chinese medical services company that uses artificial intelligence (AI).
CMB International Capital, a private equity unit of China Merchants Bank, has led a $100 million Series B round for US and China-based biopharmaceutical developer Apollomics.
Nreal, a China-based company that makes advanced virtual reality glasses that resemble normal sunglasses, has raised $15 million in Series A funding from investors including Shunwei Capital.
VC fundraising has been on a roll in Asia as managers raise larger sums to address fast-growing investment opportunities. GPs must consider what – and how much – makes them stand out from the crowd
360 Enterprise Security, a Chinese B2B internet security software provider that spun-out from Qihoo 360, has closed a Series B round of funding worth RMB900 million ($132 million), achieving a valuation of RMB20.6 billion.
Indian managed accommodation platform operator Zolo has raised $30 million in Series B funding from a group of investors including IDFC Alternatives.
China’s Loyal Valley Capital has led a $160 million funding round for Beijing Innocare, a biotechnology developer focused on immuno-oncology and autoimmune diseases.
WeRide.ai, a Chinese autonomous driving technology specialist formerly known as Jingchi.ai, has raised several hundred millions of US dollars in an extended Series A round led by local artificial intelligence (AI) company SenseTime.
New Alliance Capital has led a $45 million Series A round for China-based contract research and manufacturing services provider Thousand Oaks Biopharmaceuticals, with participation by Addor Capital and several other healthcare-focused investors.
Baraja, an Australia-based start-up developing guidance technology for autonomous vehicles, has raised a $32 million Series A round from investors including Sequoia China and Blackbird Ventures.
Chinese commercial rocket developer iSpace has completed an extended Series A round of undisclosed size led by CDH Investments, with participation from Matrix Partners China and local VC Dianke Xinghe.
Indian venture capital firm Iron Pillar Capital Management has led a $22 million Series D round for Vyome Therapeutics, a domestic pharmaceuticals developer focused on skin diseases.
Advantech Capital has led a $55 million Series B funding round for China’s Connect Biopharmaceuticals with support from Qiming Venture Partners.
US insurance giant Aflac has invested $20 million in Singapore Life, a digitally-focused financial technology start-up backed by UK private equity investor IPGL.
Antengene Corporation, a Chinese biopharmaceutical company focused on oncology drugs and therapies, has raised $120 million in a Series B round led by Boyu Capital and FountainVest Partners.
Hong Kong-based Bowtie Life Insurance has raised $30 million in Series A funding and become the first company in the territory to receive a “virtual” license to provide online-only services.